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Abstract
Objectives: To describe the drug history and co-existing
psycho-social problems among under-19 year olds
accessing treatment for opiate dependency, including
methadone maintenance, and examine for any gender
differences. 
Method: A descriptive study of under-19 years assessed
at the largest drug treatment clinic in Dublin, Ireland,
between October 2000 and September 2006. Data was
obtained through review of case notes, assessment
questionnaires and urine drug screens.
Results: Eighty-six young people were included. Their
mean age was 16.8 years. Forty-six (54%) were female.
Only 26 (30%) reported an intact family of origin. Twenty-
three (27%) had been in care. Mean age for first use of any
illicit drug was 12.4 years, and for heroin was 14.8 years.
The mean age of leaving school was 14.4 years; 42 (49%)
first tried heroin after leaving school. Forty-one (48%) had
a history of homelessness. Forty-four (51%) had previously
injected; 26 (30%) were currently injecting. Fifty-six (65%)
had not been screened for blood-borne diseases; twenty-
one (24%) subsequently tested positive for hepatitis C.
Thirty-eight (48%) had previous convictions; 33 (38%) were
facing charges. Forty-five (52%) had previously seen a
psychiatrist; nine (11%) had received inpatient psychiatric
treatment. Boys were more likely to leave school early, have
a substance-abusing sibling, and to have a past conviction.
Girls were more likely to have a partner, and have taken a
deliberate overdose.
Conclusions: This study highlights the multiple and
complex needs of teenagers abusing opiates. Services
seeking to meet their needs will require a broad range of
interventions and excellent interagency co-operation.
Key words: Adolescents; Teenagers; Opiate-dependency;
Methadone maintenance; Gender differences; Ireland.
Introduction
Internationally, the misuse of heroin by teenagers is a grow-
ing problem. The treatment of these young people poses
different challenges compared to the treatment of adults. In
contrast to adults, research specific to opiate dependent
youth is limited.1,2 Hopfer et al highlighted the psychiatric co-
morbidity and poly-substance misuse associated with heroin
using youths, and the higher treatment retention in those
services using methadone.1 These teenagers often have
problems in other areas such as physical health, family prob-
lems, housing issues, criminal behaviour, education deficits,
lack of occupational training and unemployment.3-5
Ireland and Dublin in particular, has a high prevalence of
young opiate misusers relative to other European countries.6
Kelly et al estimated that in Dublin in 2000-2001, about 3%
of males and 2% of females’ aged 15-24 misused opiates.7
Heroin misuse in Dublin increased dramatically during the
1990’s, against a backdrop of a rise in the ecstasy associ-
ated ‘rave’ scene.8 Smyth and O’Brien reported a 20-fold
increase in under-18s seeking treatment for heroin misuse
during the 1990s, compared to a five-fold increase in the
numbers of adults. Overall, 20% of those presenting to
addiction services in Dublin during the 1990s were under 18
years old, and in 48% of these subjects, the main drug of
abuse was an opiate.9
As the decade progressed, increasing proportions of these
teenagers were female, homeless, and injecting re-emerged
as a preferred route of heroin use. These trends were also
evident in a study of first time attendees to Dublin needle
exchange programmes, which showed that the proportion of
young injectors, especially females, increased from 13%-
27% between 1990 and 1997.10
Reviewing the UK experience, Burniston et al concluded
that there was no evidence that the abstinence approach
worked with young people, and that a treatment-focus on the
immediate goal of abstinence may instead discourage
engagement and retention in treatment.11 The American
Academy of Child and Adolescent Psychiatry guidelines
(1998) acknowledged the priority of engagement and harm
reduction, with abstinence as a long-term goal.12
For adults, methadone facilitates engagement and reten-
tion in treatment and through substitution, promotes and
supports abstinence from heroin. Treatment and cost effec-
tiveness is now firmly established.13-16 However, even for the
treatment of adult opiate dependency, the use of methadone
has always been controversial.17
For developmental reasons, opiate dependent teenagers
may be exposed to even greater risks because cognitive abil-
ity has not fully matured to be able to accurately judge
short-term risks and longer-term hazards associated with
drug use. It has been firmly established that the younger a
person initiates substance use, especially before the age of
15, the greater the risk of serious health consequences and
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Total Group Males Females p value
Number (%) Number (%) Number (%)
Total group 86 40 (46) 46 (54)
Education
Currently in school 5 (6) 1 (3) 4 (9) 0.22
Accommodation
Currently living with parents 50 (58) 22 (55) 28 (61) 0.42
Ever homeless 41 (48) 19 (48) 22 (48) 0.98
Homeless in last 30 days 26 (30) 14 (35) 12 (26) 0.37
History of being in care 23 (27) 14 (35) 9 (20) 0.11
Family History
Parental alcohol abuse 46 (58) 22 (59) 24 (56) 0.74
Parental opiate abuse 11 (13) 6 (16) 5 (11) 0.53
Sibling alcohol abuse 11 (16) 9 (29) 2 (5) 0.007
Sibling opiate abuse 38 (45) 23 (58) 15 (33) 0.025
Relationships
Has a current partner 44 (52) 10 (25) 34 (76) < 0.001
Current partner uses opiates 38 (86) 8 (80) 30 (88) 0.50
Main opiate of abuse
Heroin 66 (77) 29 (73) 37 (80) 0.50
Methadone 1 (1) 1 (3) 0 (0) 0.46
Heroin and methadone 19 (22) 10 (25) 9 (20) 0.54
Secondary drug abuse
Benzodiazepines
Lifetime 80 (93) 37 (92) 43 (93) 0.86
Past month 42 (49) 22 (55) 20 (43) 0.29
Baseline urine screen positive 33 (39) 16 (40) 17 (38) 0.83
Methadone
Lifetime 67 (86) 33 (89) 34 (83) 0.43
Past month 44 (52) 24 (61) 20 (43) 0.10
Baseline urine screen positive 39 (46) 20 (50) 19 (42) 0.47
Cocaine
Lifetime 57 (73) 27 (75) 30 (73) 0.72
Past month 10 (12) 7 (18) 3 (7) 0.11
Baseline urine screen positive 2 (2) 2 (5) 0 (0) 0.13
Route of heroin Use
Mainly injecting 26 (30) 14 (35) 12 (26) 0.37
Ever previously Injected 44 (51) 21 (53) 23 (50) 0.82
Criminal Behavior
Past convictions 41 (48) 25 (63) 16 (35) 0.02
Past imprisonment 25 (29) 15 (38) 10 (22) 0.16
Current charges 33 (38) 17 (43) 16 (35) 0.16
Psychiatric History
Previous psychiatric contact 45 (52) 23 (58) 22 (48) 0.37
Past inpatient psychiatric treatment 9 (11) 3 (8) 6 (13) 0.40
History of deliberate overdose 17 (21) 3 (8) 14 (32) 0.007
History of other DSH 21 (25) 8 (20) 13 (29) 0.34
Hepatitis C status
Not tested prior to assessment 56     (65) 26 (30) 30 (35) 0.99
Positive for antibody to HCV 21 (24) 9 (23) 12 (26) 0.90
HCV positive and history of injection 18 (45) 7 11
Data missing in one case for ‘ever been in care’, ‘HCV status’, ‘sibling opiate abuse’ and ‘other DSH’.  Data missing in two cases for ‘current partner’. Data missing in three
cases for ‘current partner uses opiates’, ‘History of deliberate overdose’, ‘History of other DSH’ and ‘Parental Opiate abuse’.  Data missing in five cases for ‘past
imprisonment.  Data missing in six cases for ‘past convictions’ and ‘Parental Alcohol abuse’.  Data missing in seven cases for ‘Current Charges’.  Data missing in 17 cases
for ‘Sibling Alcohol abuse’.  Fourteen cases with no recorded test at the National Virus Reference Laboratory.  
Table 1: Characteristics of 86 opiate dependent teenagers accessing opiate substitution treatment, by gender
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continued substance use into adulthood.18,19 Despite the
potential increased risks associated with opiate-dependent
teenagers, there is ongoing debate about the use of
methadone in teenagers, so that the threshold to use
methadone is often higher. 
In the USA, methadone maintenance is only a legal option
for adolescents with two documented failures of drug-free
detoxification.1 Some European countries specifically prevent
doctors from prescribing methadone to those who are under-
18 years of age. These practices expose heroin-dependent
young people to the risks of continued drug use. In the UK,
Illana Chrome adopted a more pragmatic approach, by
providing methadone treatment to teenagers on the basis of
an established diagnosis of opiate dependency, irrespective
of age, using a multidisciplinary approach within an adoles-
cent friendly unit.3 The importance of providing treatment
separate to adults and in a youth friendly environment has
been highlighted as best practice.19,20
In recognition of these recommendations and the extent of
teenage heroin misuse, Ireland’s National Drug Strategy
2001-2008 identified the need for a dedicated Adolescent
addiction service.21 We sought to describe the patterns of
substance use and psychosocial problems of under-19 year
old opiate-dependent teenagers presenting to a specialist
adolescent opiate treatment service in Dublin, Ireland, and to
examine for gender differences. 
Methods
Study design
This study is a retrospective descriptive study of opiate-
dependent young people at treatment entry, who were
commenced on opiate substitution treatment between Janu-
ary 2001 and October 2006. The diagnosis of
opiate-dependency was made by a psychiatrist using ICD-10
criteria, supported by review of three supervised urine drug
screens taken at intervals during the assessment period. 
Sociodemographic data was obtained from review of semi-
structured screening questionnaires and the doctor’s case
notes. The results of the urine drug screens were also
recorded. Actual hepatitis C status was later confirmed through
the records of the National Virus Reference Laboratory.
Participants
To be included, subjects had to be under-19 and to have
commenced methadone treatment. Subjects were identified
from the Central Treatment List, a national register of all
people prescribed methadone for the treatment of opiate-
dependency.
Setting
The Young Persons Programme (YPP) is a treatment
service set up for under-19 year old young people with seri-
ous drug problems. It is located within the Drug Treatment
Central Board (DTCB), on a separate floor to the adult
services. The DTCB is a tertiary referral service and is the
largest and longest established addiction treatment clinic in
Ireland. The YPP grew out of an initiative started in March
2001, when a nurse and two project workers were appointed
specifically to identify, engage and support increasing
numbers of young people attending for treatment with the
adult services. 
The multidisciplinary team gradually expanded to include
input from a social worker, a family therapist, a senior trainee
psychiatric doctor and a clinical Psychologist. The team is
lead by consultant child and adolescent psychiatrists.
Methadone is dispensed within this unit by staff of the YPP,
as part of an extensive care-plan that seeks to address the
biological, psychological and social needs of the young
person, in collaboration with external agencies.
In recognition of the demonstrated effectiveness of family-
based interventions on engagement, retention and treatment
outcome,22,23 family therapy is an important part of the treat-
ment approach of the YPP. Each teenager is also encouraged
to attend individual counselling, utilising strategies from
supportive psychotherapy, solution focused therapy, CBT or
insight orientated psychotherapy at various stages of treat-
ment. 
In addition, all staff members within the team receive train-
ing in motivational enhancement therapy. Urine drug screens
are done twice weekly. Based upon results of urine screens,
contingency management approaches are utilised, including
provision of methadone ‘takeaways’ and provision of vouch-
ers. 
Characteristic1 Total Group Males Females p value
IQR IQR IQR
Age (mean) 16.8 (16-17) 16.8 (16-17) 16.8 (16-18) 0.90
Age of school leaving (mean) 14.4 (14-16) 13.9 (13-15) 14.9 (14-16) 0.01
Age first heroin use (mean) 14.8 (14-16) 14.6 (13-16) 15.0 (14-16) 0.16
Age first illegal drug use (Mean) 12.4 (12-14) 12.1 (11-14) 12.7 (12-14) 0.14
Age first injected (mean) 15.9 (15-17) 16.2 (16-17) 15.7 (15-17) 0.12
Months of regular opiate use (median) 12.0 (6-24) 15.0 (6-24) 12.0 (6-24) 0.51
Average number of ‘bags’ of heroin per day2 3.5 (2.5-5) 3.5 (2.5-5) 3.5 (2.5-5) 0.63
1 Data missing in one case for ‘Months of regular opiate use’. Data missing in two cases for ‘Age first illegal drug use’. Data missing in three cases for ‘Average number of
bags of heroin per day’ and months of regular opiate use. Data missing in nine cases for ‘Age of school leaving’.  2 one ‘bag’ = 0.113g.
Table 2: Quantitative characteristics of 86 opiate dependent teenagers accessing opiate substitution treatment by gender
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Statistics 
Statistical analysis was undertaken using SPSS version
14. In order to explore for gender differences, dichotomous
variables were examined via the Pearson Chi Square test.
Where cells had an expected count of less than five, the
Fisher’s Exact Test was utilised. Normally distributed quanti-
tative variables were examined by the Independent t-test.
Other quantitative variables were examined using the Mann
Whitney U-test. The P value was set at 0.05. 
Results
Eighty-six teenagers were commenced on opiate substitu-
tion treatment during the study period. Some of the
characteristics of the group are outlined in Tables 1 and 2.
School and occupation history
Only one teenager reported completion of the full
secondary school program. The rest of these teenagers left
school early. Among those with a recorded reason for school
leaving (68 cases), 11 (13%) transferred to alternative youth
education and training schemes, 12 (14%) were expelled,
whilst 43 (50%) simply dropped out. Forty-nine (57%) said
they had never worked after leaving school. 
Family history
Many of these teenagers came from a dysfunctional family
background as suggested by childhood involvement with
social services (including foster care) in 45 cases (52%;
unknown = 8). When asked to describe their primary support
family, 26 (30%) said both biological parents were together;
34 cases (40%) came from a single-parent household (28
cases single-mother), and 19 (22%) from a parent-partner
household. Three sought support from another relative, two
from their adopted family; one young person had no contact
with any family member. A family history of alcohol and
substance abuse was common (see Table 1). Both parents
had a history of alcohol misuse in 10 cases, and a history of
opiate abuse in four cases.
Current social circumstances
Although half were living with their parent(s), three each
were living with either another relative, a foster family or in a
squat; eight were living with a partner, six with friends and 13
in hostel accommodation. Thirty-eight young people had a
partner who also used heroin; gender did not predict a
heroin-using partner. Five girls and one boy had parented a
child prior to entering treatment.
Psychiatric and forensic history
Just over half of the treatment entrants had previously had
contact with mental health services, for a reason other than
substance misuse. Most also had past contact with the crim-
inal justice system.
Drug history
The median age of first use of an illicit drug was 12 years
(range 8-17) and in 83% of cases this was cannabis. Thirty-
four (40%) first used heroin before their 15th birthday (see
Table 2). Nearly half first tried heroin after leaving the educa-
tion system. The mean time from first heroin use to treatment
was two years (SD = 1.3 yrs). Among those with a history of
injecting, the median duration of injecting prior to assessment
was one year. The majority had used ‘street’ methadone, and
this was recent in half of all treatment entrants.
Serology
At assessment, 19 (22%) of these young people reported
that they were hepatitis C virus (HCV) negative, two (2%)
that they were HCV-positive, 56 (65%) that they had never
been tested before, and nine (10%) did not know if they had
ever been screened for blood borne diseases. Fifteen of
those young people currently injecting, and 24 with a history
of injection, had not been tested for blood-borne diseases.
When their actual HCV status was checked as part of their
assessment, 21 (24%) were HCV antibody-positive. Of
concern, 14 had declined testing. No young person tested
positive for HIV.
Significant finding by gender
Boys demonstrated significantly earlier school leaving.
Boys were also more likely have a past conviction, and to
report sibling opiate abuse and sibling alcohol abuse. Girls
were more likely to have a current partner and a history of
taking a deliberate overdose.
Discussion
As far as the authors are aware, this is the largest cohort
of opiate dependent teenagers described in the international
literature. This study highlights the significant levels of
psychosocial adversity in the background of these opiate-
dependant youths. This includes early onset of drug
experimentation, polysubstance misuse, non-intact family of
origin, family history of drug and alcohol misuse, mental
health problems, involvement of social services, early school
leaving, lack of training and unemployment, criminality and a
history of homelessness. 
These opiate-dependent teenagers in Dublin are compa-
rable to those described in the North-west of England by
Chrome.3 However, the Dublin teenagers demonstrated
earlier initiation into drug use (12.4 versus 13.3 years), and
earlier first use of heroin (14.8 versus 15.8 years). However,
fewer of the Dublin teenagers were currently injecting (28%
v 62.5%) or had a histories of ever injecting (46% v 70.8%),
and the time from first use of heroin to assessment was
longer in Dublin (24 v 16 months). 
In Ireland, early school leaving is common among young
substance misusers.24 Cannabis was the first drug used by
83% of these young people at a mean age 12.4 years.
Research has clearly demonstrated an association between
cannabis use and poor educational outcomes, especially
early school leaving.25,26 Though drugs may have contributed
to poor academic performance and early school leaving, an
unexpected finding of this study was that 49% of these
young people first tried heroin after leaving school. This high-
lights a missed opportunity to intervene before some of these
early school-leavers have progressed to heroin use. Early
school leavers have been identified as being at high-risk of
problematic drug use.27 Those early school leavers not
employed or attending alternative education services are
particularly vulnerable, as well as marginalised and difficult to
access. In this study, forty-nine cases (57%) never worked
after leaving school. Mayock28 looked in detail at adolescents
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living in a deprived inner-city community in Dublin. She
concluded that there is a need to target these young people
using innovative approaches such as outreach services and
young people trained as peer educators to establish and
maintain contact with these adolescents at the earliest stage
of this critical juncture in their lives. 
Such strategies may prevent some of these early school
leavers from progressing further in their drug use to heroin
experimentation and dependency, and engage those already
using heroin into treatment at an earlier stage. Instead these
early school-leavers may be socialising with other teenagers
not going to school, and older unemployed youths, in an
unsupervised environment of drug use.
Homelessness and drug misuse are interrelated and often
create a vicious cycle. In a recent Irish study on homeless-
ness,29 family conflict was the most common reason for
becoming homeless, and drug abuse the second most
common reason for continued homelessness, after lack of
access to alternative housing. Many of these young people
said they were homeless in the month before assessment
(29%), or had a history of homelessness (45%). A teenager
faced with intolerable home circumstances cannot easily
leave the family home through renting alternative accommo-
dation. Instead their only option may be to make themselves
homeless. This exposes the young person to a marginalised
group, many of whom are older, using drugs and/or engaged
in crime, through which they may accumulate further harm,
including progression to injection. By engaging these young
people in treatment, present housing issues can be
stabilised, future homelessness prevented, thus hopefully
reducing risk exposure. 
Poly substance issues
The majority of these teenagers have used a variety of
different drugs and most have used methadone. Tackling
polydrug misuse increases the treatment challenges in this
group. Research on adult populations indicates that heroin
dependent patients use diverted methadone generally as a
strategy to manage withdrawal symptoms, and also for hedo-
nic effects occasionally. These factors are likely to underpin
the methadone misuse reported by this young population. 
Gender issues
In contrast to adult addiction services, in this study more
females than males entered treatment. This suggests a
continuation of previously demonstrated trends, with females
gradually accounting for an increased proportion of the
under-18 opiate misusing treatment attendees in Dublin
during the 1990s.9 Whereas a decade ago males were more
at risk of opiate abuse, now male and female teenagers are
equally at risk. This has implications for service provision. 
The males and females presented generally with a similar
profile of needs. However, males were more likely to report a
background of familial drug and alcohol abuse and greater
forensic problems. 
Females reported greater past suicidal behaviour and they
were also much more likely to be in a current relationship, and
these relationships were invariably with other opiate users.
These differences may reflect different aetiological pathways
into opiate dependence between the genders. The large
number of young girls in relationships with older male heroin
users presents a significant treatment challenge. 
Jessor and Jessor have argued that from the teenager’s
perspective, substance use can be functional by assisting the
young person to solve developmental challenges and
stresses.30 As heroin in particular induces euphoria and
relieves anxiety, it may for some, provide a maladaptive solu-
tion to the difficulties of growing up in adverse
circumstances. A young person already struggling with the
challenges of adolescence may find that heroin provides relief
from stress at a time when more healthy coping mechanisms
have not fully developed. Cognitively these adolescents may
not fully appreciate the longer-term disadvantages to heroin
use. Their immediate concern and reason for seeking treat-
ment may be to control negative aspects of drug use as they
see it, such as the daily withdrawal symptoms, while not
being particularly focussed on the goal of abstinence per se.
In motivational terms,31 they may be in the action stage of
change with regard to problem areas such as homelessness,
but are at the pre-contemplative stage with regard to drug
use. Jessor and Jessor argue that unless a young person is
provided with alternative ways of relieving stress and achiev-
ing personal goals, substance use will persist.
Modern aetiological theories on teenage drug use are
multisystemic, involving a complex interplay of risk and
protective factors operating at various levels – individual,
family, neighbourhood, school and peer group – to create
pathways toward problematic substance use. 
As described by Carr, such problematic behaviour is more
likely to arise “in vulnerable youngsters who are involved in
problematic family relationships, problematic peer group rela-
tionships, and within communities where drugs are available
and other pathways towards self-fulfilment are blocked”.32 The
associations described in this study represent a snapshot of
this complex multisystemic system. 
Conclusion
These young people come from a background of major
disadvantage, family dysfunction and psychiatric co-morbid-
ity. Complete abstinence may not be their priority in seeking
treatment. Instead, they may be seeking relief from the over-
all chaos and instability in their lives. 
In order to move these teenagers towards change in their
use of drugs, treatment services need to be multidisciplinary
and flexibly employ a wide range of bio-psycho-social inter-
ventions including methadone. All of this needs to take place
against a background of efficient interagency co-operation.
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